Growth differentiation factor-15 predicts mortality and morbidity after cardiac resynchronization therapy.

Foley, Paul W X and Stegemann, Berthold and Ng, Kelvin and Ramachandran, Sud and Proudler, Anthony and Frenneaux, Michael P and Ng, Leong L and Leyva, Francisco (2009) Growth differentiation factor-15 predicts mortality and morbidity after cardiac resynchronization therapy. European Heart Journal, 30 (22). pp. 2749-57. ISSN 1522-9645.

Full text not available from this repository.

Abstract

Pre-implant GDF-15 is a strong predictor of mortality and morbidity after CRT, independent of NT pro-BNP. The predictive value of these analytes is enhanced by combined measurement.

Item Type:	Article
Subjects:	WG Cardiovascular system. Cardiology
Divisions:	Clinical Support > Pathology Emergency Services > Cardiology
Related URLs:	http://www.ncbi.nlm.nih.gov/pmc/articles...
Depositing User:	Sophie Rollason
Date Deposited:	13 May 2013 09:22
Last Modified:	13 May 2013 09:22
URI:	http://www.repository.heartofengland.nhs.uk/id/eprint/43

Actions (login required)

View Item